Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA enforcement actions

Executive Summary

Included forty-nine regulatory letters and 16 seizures during the first six months of 1990, Office of Compliance Deputy Director Sammie Young reported Sept. 18 in Bethesda, Md. Fourteen of the regulatory letters and eight of the seizures involved violations of Good Manufacturing Practices (GMPs). In all of 1989, 115 regulatory letters (including 48 concerning GMPs) were sent compared to 109 reg letters (35 for GMP violations) in 1988; and 106 (64 GMP) in 1987. There were 30 seizures (including 9 GMP violations) in 1989; 50 (9 GMP) in 1988; 50 (15 GMP) in 1987 and 83 (29 GMP) in 1986.
UsernamePublicRestriction

Register

PS018105

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel